130 results
8-K
HGENQ
Humanigen, Inc
8 Jan 24
Entry into a Material Definitive Agreement
5:02pm
and partners at closing will be the responsibility of Taran.
The Company’s entrance into the Asset Purchase Agreement followed an extensive effort
8-K
EX-2.1
HGENQ
Humanigen, Inc
8 Jan 24
Entry into a Material Definitive Agreement
5:02pm
to such Assigned Contract shall be the responsibility of Seller until such Assigned Contract is either assumed by Seller and assigned to Purchaser or rejected … that Purchaser shall have no Liability, obligation or responsibility for any Liabilities, Claims, Encumbrances or other obligation of Seller arising under
424B5
HGENQ
Humanigen, Inc
14 Apr 22
Prospectus supplement for primary offering
5:27pm
not authorized anyone to provide you with any information other than that contained in this prospectus. We and Cantor Fitzgerald take no responsibility
8-K
EX-99.1
6d5rfd
20 Oct 21
Humanigen Elects John Hohneker, MD, and Kevin Xie, PhD, to Board of Directors
9:13am
424B5
vd6lwrn9ir
13 Aug 21
Prospectus supplement for primary offering
5:08pm
8-K
EX-1.1
wn8dkf1sy
2 Apr 21
Other Events
5:00pm
424B5
uy20sn6tu
1 Apr 21
Prospectus supplement for primary offering
6:02am
424B5
ax18cgqi1s
29 Mar 21
Prospectus supplement for primary offering
4:39pm
8-K
EX-10.1
v2i8mo0brer384zd
14 Jan 21
Humanigen and EVERSANA Announce Partnership to Support the Launch and Commercialization of Lenzilumab for the Treatment of COVID-19
4:30pm
424B5
9vng4
31 Dec 20
Prospectus supplement for primary offering
4:46pm
8-K
EX-1.1
8eawn
31 Dec 20
Other Events
4:37pm